5-33987132-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_014324.6(AMACR):c.*1961G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0269 in 152,078 control chromosomes in the GnomAD database, including 184 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.027 ( 184 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
AMACR
NM_014324.6 3_prime_UTR
NM_014324.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.292
Genes affected
AMACR (HGNC:451): (alpha-methylacyl-CoA racemase) This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 5-33987132-C-T is Benign according to our data. Variant chr5-33987132-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 353224.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0919 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMACR | NM_014324.6 | c.*1961G>A | 3_prime_UTR_variant | 5/5 | ENST00000335606.11 | NP_055139.4 | ||
C1QTNF3-AMACR | NR_037951.1 | n.3466G>A | non_coding_transcript_exon_variant | 9/9 | ||||
AMACR | NM_001167595.2 | c.*1176G>A | 3_prime_UTR_variant | 6/6 | NP_001161067.1 | |||
AMACR | NM_203382.3 | c.*2352G>A | 3_prime_UTR_variant | 4/4 | NP_976316.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMACR | ENST00000335606.11 | c.*1961G>A | 3_prime_UTR_variant | 5/5 | 1 | NM_014324.6 | ENSP00000334424 | P1 | ||
AMACR | ENST00000382072.6 | downstream_gene_variant | 1 | ENSP00000371504 |
Frequencies
GnomAD3 genomes AF: 0.0268 AC: 4068AN: 151960Hom.: 183 Cov.: 32
GnomAD3 genomes
AF:
AC:
4068
AN:
151960
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 338Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 272
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
338
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
272
Gnomad4 AFR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0269 AC: 4089AN: 152078Hom.: 184 Cov.: 32 AF XY: 0.0269 AC XY: 2002AN XY: 74352
GnomAD4 genome
AF:
AC:
4089
AN:
152078
Hom.:
Cov.:
32
AF XY:
AC XY:
2002
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
21
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Oculocutaneous albinism Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Alpha-methylacyl-CoA racemase deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at